Memantine |
Memantine Products |
| An animal model evaluation of the therapeutic use of memantine, and memantine and tacrine, for the treatment of Alzheimer's disease Catherine E. Creeley ProQuest / UMI ProQuest / UMI |
Sale Price: $69.99
|
| Pocket Pharma: Memantine and Alzheimer's Disease (Pocket Pharma) Bengt Winblad Science Press Science Press |
Sale Price: $15.95
|
| Memantine shows efficacy for mild Alzheimer's disease.(Rx): An article from: Internal Medicine News Mitchel L. Zoler International Medical News Group International Medical News Group |
Sale Price: $5.95
|
| Memantine improves cognition in Alzheimer's.(Geriatric Psychiatry) : An article from: Clinical Psychiatry News Robert Finn International Medical News Group International Medical News Group |
Sale Price: $5.95
|
| Memantine also effective in mild to moderate Alzheimer's disease.(Geriatric Psychiatry): An article from: Clinical Psychiatry News Bruce Jancin International Medical News Group International Medical News Group |
Sale Price: $5.95
|
| FDA approves first drug for advanced stage Alzheimer's: NMDA antagonist: advisory panel found memantine safe and effective, though not overwhelmingly so.(News) : An article from: Family Practice News Elizabeth Mechcatie International Medical News Group International Medical News Group |
Sale Price: $5.95
|
| U.S. approval sought for memantine to slow severe cognitive decline. (New Class of Drugs).: An article from: Internal Medicine News Miriam E. Tucker International Medical News Group The Gale Group International Medical News Group |
Sale Price: $5.95
|
| First drug for advanced Alzheimer's approved: NMDA antagonist memantine will be available in January.: An article from: Clinical Psychiatry News Elizabeth Mechcatie International Medical News Group The Gale Group International Medical News Group |
Sale Price: $5.95
|
| Memantine can cut Alzheimer's-related costs. (FDA Approval Expected by Year-End).: An article from: Clinical Psychiatry News Norra MacReady International Medical News Group The Gale Group International Medical News Group |
Sale Price: $5.95
|
| Memantine shows efficacy for mild to moderate AD in phase III study.(Geriatric Psychiatry): An article from: Clinical Psychiatry News Mitchel L. Zoler International Medical News Group International Medical News Group |
Sale Price: $5.95
|
| Memantine may reduce agitation in AD patients: the investigators were surprised by the magnitude and consistency of the drug's effect on behavior.(Geriatrics)(Alzheimer's ... An article from: Internal Medicine News Doug Brunk International Medical News Group International Medical News Group |
Sale Price: $5.95
|
| FDA panel approves memantine for moderate to severe Alzheimer's: NMDA receptor antagonist.(Rx): An article from: Internal Medicine News Elizabeth Mechcatie International Medical News Group The Gale Group International Medical News Group |
Sale Price: $5.95
|
| New option for moderate to severe Alzheimer's: memantine available in 2004.(Rx)(N-methyl-D-aspartate (NMDA) receptor antagonist ): An article from: Internal Medicine News Elizabeth Mechcatie International Medical News Group The Gale Group International Medical News Group |
Sale Price: $5.95
|
| Panel backs memantine for moderate, severe Alzheimer's: FDA approval likely this year.(News): An article from: Clinical Psychiatry News Elizabeth Mechcatie International Medical News Group The Gale Group International Medical News Group |
Sale Price: $5.95
|

Not Signed In - 


